Inventor · disambiguated record
Stephen Hoge
Also filed as: HOGE STEPHEN · HOGE STEPHEN G
62 granted patents·41 pending applications·960 citations·filing 1997–2025
99Inventor score
Top patents by PatentIndex Score
103 records- 0199US9597380B2Terminally modified RNAMODERNATX INC·Filed 2013·Granted Mar 21, 2017·143 cites·13 claims
- 0299US8980864B2Compositions and methods of altering cholesterol levelsMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 17, 2015·143 cites·5 claims
- 0398US11344504B1Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2021·Granted May 31, 2022·4 cites·29 claims
- 0498US10653712B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2018·Granted May 19, 2020·73 cites·18 claims
- 0598US10285950B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted May 14, 2019·13 cites·20 claims
- 0698US10207010B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2017·Granted Feb 19, 2019·104 cites·24 claims
- 0798US10172808B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jan 8, 2019·19 cites·18 claims
- 0897US11285222B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2019·Granted Mar 29, 2022·10 cites·31 claims
- 0997US11071716B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2020·Granted Jul 27, 2021·3 cites·20 claims
- 1097US11027025B2Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of useMODERNATX INC·Filed 2014·Granted Jun 8, 2021·40 cites·3 claims
- 1197US10646549B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2018·Granted May 12, 2020·13 cites·20 claims
- 1297US10072057B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Granted Sep 11, 2018·31 cites·21 claims
- 1397US9751925B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2015·Granted Sep 5, 2017·32 cites·29 claims
- 1496US11000573B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2020·Granted May 11, 2021·3 cites·20 claims
- 1596US10406113B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·30 claims
- 1695US11596609B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Mar 7, 2023·1 cites·20 claims
- 1795US11504337B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2019·Granted Nov 22, 2022·12 cites·19 claims
- 1895US11202793B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2017·Granted Dec 21, 2021·15 cites·23 claims
- 1995US10925935B2Terminally Modified RNAMODERNA TX INC·Filed 2018·Granted Feb 23, 2021·18 cites·37 claims
- 2095US10322090B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 2195US10322091B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 2295US10155029B2Terminally modified RNAMODERNATX INC·Filed 2017·Granted Dec 18, 2018·12 cites·15 claims
- 2393US11786607B2RNA formulationsMODERNATX INC·Filed 2018·Granted Oct 17, 2023·25 cites·22 claims
- 2492US12246029B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2021·Granted Mar 11, 2025·1 cites·34 claims
- 2592US12233084B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2021·Granted Feb 25, 2025·1 cites·36 claims
- 2692US10973917B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2019·Granted Apr 13, 2021·4 cites·27 claims
- 2792US10485885B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2018·Granted Nov 26, 2019·8 cites·30 claims
- 2892US10335486B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2018·Granted Jul 2, 2019·8 cites·23 claims
- 2991US11001861B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2017·Granted May 11, 2021·11 cites·50 claims
- 3091US10494636B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 3, 2019·3 cites·8 claims
- 3191US10258698B2Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2014·Granted Apr 16, 2019·12 cites·6 claims
- 3290US11311602B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2021·Granted Apr 26, 2022·1 cites·31 claims
- 3390US10556018B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2017·Granted Feb 11, 2020·6 cites·28 claims
- 3489US11185510B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2019·Granted Nov 30, 2021·1 cites·26 claims
- 3589US10849920B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2016·Granted Dec 1, 2020·3 cites·16 claims
- 3689US2025170228A1Terminally modified rnaMODERNATX INC·Filed 2024·Application pending·0 cites
- 3788US10730924B2Polynucleotides encoding relaxinMODERNATX INC·Filed 2018·Granted Aug 4, 2020·5 cites·21 claims
- 3885US11590157B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2020·Granted Feb 28, 2023·1 cites·25 claims
- 3984US11649461B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2019·Granted May 16, 2023·1 cites·21 claims
- 4084US10993918B2Polynucleotides encoding citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2017·Granted May 4, 2021·2 cites·50 claims
- 4183US12246030B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2023·Granted Mar 11, 2025·0 cites·32 claims
- 4283US2023041964A1Combinations of mrnas encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 4382US11801227B2Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNATX INC·Filed 2017·Granted Oct 31, 2023·1 cites·30 claims
- 4482US11571463B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2022·Granted Feb 7, 2023·0 cites·23 claims
- 4582US2024024422A1Polynucleotides encoding interleukin-12 (il12) and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 4682US2023323371A1Polynucleotides encoding alpha-galactosidase a for the treatment of fabry diseaseMODERNATX INC·Filed 2023·Application pending·0 cites
- 4782US2023270685A1POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASEMODERNATX INC·Filed 2022·Application pending·0 cites
- 4881US12491260B2Compositions and methods for delivery of agentsMODERNATX INC·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 4981US2023346928A1Mrna combination therapy for the treatment of cancerMODERNATX INC·Filed 2023·Application pending·0 cites
- 5079US2025275999A1High purity rna compositions and methods for preparation thereofMODERNATX INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Hoge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →